Pavel L Katsel, PhD
- ASSOCIATE PROFESSOR | Psychiatry
Dr. Katsel, since joining the Department of Psychiatry, has conducted research in the Division of Basic Science directed by Dr. Haroutunian. His primary areas of interest are the neurobiology of Alzheimer's disease and schizophrenia. Dr. Katsel applies molecular biological techniques to understand the biological substrates of schizophrenia and dementia. He is also a contributor to Mount Sinai's Silvio Conte Center for Neuroscience and the Alzheimer's Disease Research Center. Dr. Katsel's most recent publications focus on understanding molecular mechanism underlining the oligodendroglial and myelin deficits in schizophrenia as well as on sphingolipid metabolism abnormalities during the earliest stages of dementia and Alzheimer's disease.
Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB, Haroutunian V. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology 2008 Mar 5; Epub ahead of print.
Haroutunian V, Katsel P, Schmeidler J. Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia. Neurobiol Aging 2007;.
Katsel P, Li C, Haroutunian V. Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer's Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer's Disease?. Neurochem. Res 2007; 32(4-5): 845-856.
Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int. J Neuropsychopharmacol 2007; 10(4): 565-573.
Haroutunian V, Katsel P, Dracheva S, Davis KL. The Human Homolog of QKI Gene Affected in the Severe Dysmyelination . Amer. J Psych 2006; 163: 1834-1837.